Φορτώνει......
The original sins of clinical trials with intravenous immunoglobulins in sepsis
Intravenous immunoglobulins (IVIGs) have not yet demonstrated robust evidence in the benefit for treatment of sepsis. In spite of multiple clinical trials performed with IVIG in sepsis, it remains an experimental therapy for this severe condition. Nonetheless, these trials do not address a number of...
Αποθηκεύτηκε σε:
| Τόπος έκδοσης: | Crit Care |
|---|---|
| Κύριοι συγγραφείς: | , , , , , , , |
| Μορφή: | Artigo |
| Γλώσσα: | Inglês |
| Έκδοση: |
BioMed Central
2015
|
| Θέματα: | |
| Διαθέσιμο Online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4343266/ https://ncbi.nlm.nih.gov/pubmed/25882822 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13054-015-0793-0 |
| Ετικέτες: |
Προσθήκη ετικέτας
Δεν υπάρχουν, Καταχωρήστε ετικέτα πρώτοι!
|